Podimo ApS develops a platform, which provides podcast streaming and download services. The company provides audio content to the users. Podimo ApS was founded in 2019 and is headquartered in Copenhagen, Denmark.
Corti is an artificial intelligence platform designed to assist emergency medical dispatchers and healthcare providers in making critical, life-saving decisions. The platform focuses on medical triaging, aiming to reduce errors and enhance the accuracy of human decision-making. By employing advanced speech recognition and natural language processing, Corti analyzes patient interviews and prepares case files prior to consultations. It also suggests relevant questions to ask, enabling healthcare professionals to understand patient situations more effectively. Through these capabilities, Corti aims to improve the speed and accuracy of decision-making in emergency medical contexts, ultimately contributing to better patient outcomes.
Kobaj operates an online marketplace focused on the buying and selling of wine, connecting winemakers directly with customers across Europe. The platform enables winemakers to showcase their products and offers customers access to competitive pricing typically reserved for importers and wine merchants. In addition to facilitating sales, Kobaj provides a range of services including co-buying, beverage manufacturing, payment processing, insurance, and logistics for the transportation of goods. This comprehensive approach enhances the e-commerce experience for both sellers and buyers in the wine industry.
Layerise ApS, founded in 2019 and based in Copenhagen, Denmark, specializes in developing product onboarding software that enhances customer experiences. The company offers a comprehensive platform that includes features such as product reminders, how-to guides, customer insights, and smart localization. By focusing on interactive customer engagement rather than traditional product manuals, Layerise enables brands to provide effective onboarding, facilitate one-tap product registrations, and create content-rich experiences. Its tools also support post-sale marketing and customer assistance, helping clients improve service quality and transform average sales into positive customer experiences.
Forecast ApS is a software development company based in Copenhagen, Denmark, that specializes in project management solutions. Founded in 2016, Forecast provides a comprehensive platform designed to help professional service organizations streamline their project and resource management. The software integrates various functionalities, including financial management, time tracking, team collaboration, and business intelligence, all powered by artificial intelligence. This intelligent platform enables users to plan, budget, and predict project outcomes effectively. By unifying project-related data, Forecast facilitates better decision-making and enhances operational efficiency, allowing teams to focus on innovation rather than administrative tasks. The company aims to shift the project management paradigm from a project-first approach to a client-first strategy, ultimately delivering improved results for businesses.
Ascelia Pharma AB is an oncology-focused drug development company based in Malmö, Sweden, specializing in orphan drugs. Founded in 2000, the company is committed to addressing unmet medical needs through the development and commercialization of innovative therapies. Its lead product, Mangoral, is a novel non-gadolinium contrast agent currently in Phase III clinical trials for MRI scans of the liver. Additionally, Ascelia is advancing Oncoral, an oral chemotherapy tablet in Phase II trials aimed at treating gastric cancer. Through these initiatives, Ascelia Pharma seeks to provide effective treatment options for patients with specific oncology needs.
IO Biotech ApS is a clinical stage biotech company developing disruptive immune therapies i.e. checkpoint/cancer vaccines. Checkpoint/cancer vaccines suppress the function of regulatory immune cells and induce inflammation in the microenvironment in addition to direct targeting of cancer cells.
Minervax is pursuing the development of a vaccine against Group B streptococcus (GBS) infections by utilizing a particular fusion protein, which has proved to elicit good protective immunity. A vaccine including this fusion protein will likely elicit protective immunity against many clinically relevant GBS strains.
Tink AB, founded in 2012 and headquartered in Stockholm, Sweden, operates as a cloud-based open banking platform that enhances financial services through its infrastructure and data products. The company offers a mobile application that allows users to track personal finances, manage money across various accounts, transfer funds, pay bills, and establish personal budgets. Key features of the application include transaction categorization, spending insights, and daily analyses. Additionally, Tink provides products such as account aggregation, payment initiation, and data enrichment, which can be utilized for standalone services or integrated into existing banking applications. The company's partnerships with major financial institutions, including ABN AMRO, BNP Paribas Fortis, Nordea, Klarna, and SEB, further bolster its position in the financial technology sector.
Galecto, Inc. is a clinical-stage biotechnology company founded in 2011, focused on developing small molecules to treat severe diseases, particularly fibrosis and cancer. The company leverages over a decade of research on the roles of galectin-3 and lysyl oxidase-like 2 (LOXL2) in fibrotic processes. Its therapeutic approach includes small-molecule inhibitors targeting these proteins. Galecto's leading product candidate, GB0139, is aimed at treating severe fibrotic lung diseases, notably idiopathic pulmonary fibrosis, while another candidate, GB1211, is a selective oral galectin-3 inhibitor intended for managing fibrosis related to non-alcoholic steatohepatitis. With a robust patent portfolio, Galecto is positioned to address critical unmet medical needs in the treatment of fibrotic and related diseases.
Layerise ApS, founded in 2019 and based in Copenhagen, Denmark, specializes in developing product onboarding software that enhances customer experiences. The company offers a comprehensive platform that includes features such as product reminders, how-to guides, customer insights, and smart localization. By focusing on interactive customer engagement rather than traditional product manuals, Layerise enables brands to provide effective onboarding, facilitate one-tap product registrations, and create content-rich experiences. Its tools also support post-sale marketing and customer assistance, helping clients improve service quality and transform average sales into positive customer experiences.
SoundBoks is a Copenhagen-based hardware start-up developing and selling battery-powered speaker.
Founded in January 2015, the company developed a shock and weatherproof design that is portable and durable, with up to 60 hours of battery life at loud volume. It also combines high SPL speaker units with a powerful amplifier in order to reach sounds with an output as high as 119db.
Finematter Aps is an online fine jewelry store founded in 2020 and based in Copenhagen, Denmark. The company operates an e-commerce platform designed to facilitate the sale of fine jewelry, showcasing locally handcrafted designer pieces, gold and silver goods, and watches. By allowing small independent jewelers to sell their creations directly to consumers, Finematter minimizes third-party retail overheads and emphasizes the unique qualities of handcrafted items. This approach not only supports local artisans but also provides consumers with access to distinctive jewelry that celebrates individuality.
Traplight Oy, established in 2010 and located in Tampere, Finland, specializes in developing mobile game communities that emphasize user-generated content. The company focuses on creating free-to-play games that are both accessible and engaging, offering players enjoyable gameplay and a sense of progression. Traplight encourages players to create and share their own games, integrating player-generated levels into the core gaming experience. The company has garnered support from prominent investors and has a team of 28 dedicated professionals working on multiple projects. Their notable title, Big Bang Racing, received recognition as one of the best apps in 2016 on the App Store. Traplight is currently preparing to soft launch its next major game, aiming to provide lasting entertainment that evolves with player preferences.
Podimo ApS develops a platform, which provides podcast streaming and download services. The company provides audio content to the users. Podimo ApS was founded in 2019 and is headquartered in Copenhagen, Denmark.
BLAST Premier is an esports entertainment company that specializes in broadcast studio shows, arena events, and online content.
IO Biotech ApS is a clinical stage biotech company developing disruptive immune therapies i.e. checkpoint/cancer vaccines. Checkpoint/cancer vaccines suppress the function of regulatory immune cells and induce inflammation in the microenvironment in addition to direct targeting of cancer cells.
Tink AB, founded in 2012 and headquartered in Stockholm, Sweden, operates as a cloud-based open banking platform that enhances financial services through its infrastructure and data products. The company offers a mobile application that allows users to track personal finances, manage money across various accounts, transfer funds, pay bills, and establish personal budgets. Key features of the application include transaction categorization, spending insights, and daily analyses. Additionally, Tink provides products such as account aggregation, payment initiation, and data enrichment, which can be utilized for standalone services or integrated into existing banking applications. The company's partnerships with major financial institutions, including ABN AMRO, BNP Paribas Fortis, Nordea, Klarna, and SEB, further bolster its position in the financial technology sector.
Forecast ApS is a software development company based in Copenhagen, Denmark, that specializes in project management solutions. Founded in 2016, Forecast provides a comprehensive platform designed to help professional service organizations streamline their project and resource management. The software integrates various functionalities, including financial management, time tracking, team collaboration, and business intelligence, all powered by artificial intelligence. This intelligent platform enables users to plan, budget, and predict project outcomes effectively. By unifying project-related data, Forecast facilitates better decision-making and enhances operational efficiency, allowing teams to focus on innovation rather than administrative tasks. The company aims to shift the project management paradigm from a project-first approach to a client-first strategy, ultimately delivering improved results for businesses.
Astralis is a Copenhagen-based professional e-sports organization recognized for its competitive teams, particularly in Counter-Strike, where it ranks among the top teams worldwide. Founded by Frederik Byskov and Jacob Lund Kristensen, along with five prominent players from the Counter-Strike team, Astralis has established itself as a significant player in the global esports industry. The organization not only operates its Counter-Strike team but also manages teams in League of Legends and FIFA, focusing on developing strong sports and entertainment brands. Astralis engages in media partnerships and channels to enhance its brand presence and connect with fans and audiences worldwide.
Forendo Pharma Oy is a drug discovery and development company based in Turku, Finland, founded in 2013. The company specializes in the tissue-specific regulation of sex hormone effects and is focused on developing innovative treatments for urological and endocrinological diseases. Its lead product, Fispemifene, is a selective estrogen receptor modulator designed to address symptoms related to low testosterone in men. Additionally, Forendo is working on a 17HSD1-inhibitor aimed at treating endometriosis. By targeting specific hormone mechanisms, Forendo Pharma seeks to enhance treatment options for both male and female health conditions, addressing unmet medical needs in these areas.
Podimo ApS develops a platform, which provides podcast streaming and download services. The company provides audio content to the users. Podimo ApS was founded in 2019 and is headquartered in Copenhagen, Denmark.
Peakon ApS, founded in 2008 and based in Copenhagen, Denmark, specializes in real-time people analytics aimed at enhancing employee engagement and retention. The Peakon platform automatically gathers employee feedback and analyzes it to provide actionable insights for organizations. It supports a diverse range of users by being available in over 50 languages and can accommodate complex organizational structures with tens of thousands of employees. Feedback can be submitted through various channels, including web, mobile browsers, SMS, kiosks, and a native app, enabling organizations to foster an environment where employees can reach their full potential.
Tink AB, founded in 2012 and headquartered in Stockholm, Sweden, operates as a cloud-based open banking platform that enhances financial services through its infrastructure and data products. The company offers a mobile application that allows users to track personal finances, manage money across various accounts, transfer funds, pay bills, and establish personal budgets. Key features of the application include transaction categorization, spending insights, and daily analyses. Additionally, Tink provides products such as account aggregation, payment initiation, and data enrichment, which can be utilized for standalone services or integrated into existing banking applications. The company's partnerships with major financial institutions, including ABN AMRO, BNP Paribas Fortis, Nordea, Klarna, and SEB, further bolster its position in the financial technology sector.
Minervax is pursuing the development of a vaccine against Group B streptococcus (GBS) infections by utilizing a particular fusion protein, which has proved to elicit good protective immunity. A vaccine including this fusion protein will likely elicit protective immunity against many clinically relevant GBS strains.
RFRSH ApS is an esports marketing and media rights company based in Copenhagen, Denmark, founded in 2016. The company specializes in developing commercial and marketing strategies for esports teams, particularly focusing on the popular game Counter-Strike. RFRSH ApS collaborates with a range of established organizations and emerging player-owned teams to enhance their brand visibility and sports performance. By representing the commercial and media rights of these teams, RFRSH connects them with leading global brands for sponsorship and marketing agreements, thereby facilitating their growth and success in the competitive esports landscape.
Templafy ApS is a B2B Software-as-a-Service company specializing in template and document management solutions. Founded in 2013 and headquartered in Copenhagen, Denmark, Templafy offers a comprehensive platform that enhances productivity, branding, and compliance across various business documents, presentations, and emails. Its services include template and content accessibility, dynamic personalization, document automation, and brand validation, catering primarily to sectors such as banking, finance, consulting, education, insurance, consumer goods, and legal services. With a user base exceeding 1.5 million, Templafy streamlines the document creation workflow, allowing communication and compliance teams to maintain control while ensuring an enjoyable user experience for employees. The company has expanded its presence internationally, with offices in the United States, Germany, the Netherlands, the United Kingdom, Singapore, Hong Kong, Australia, New Zealand, and Spain, serving a diverse range of enterprise customers globally.
Galecto, Inc. is a clinical-stage biotechnology company founded in 2011, focused on developing small molecules to treat severe diseases, particularly fibrosis and cancer. The company leverages over a decade of research on the roles of galectin-3 and lysyl oxidase-like 2 (LOXL2) in fibrotic processes. Its therapeutic approach includes small-molecule inhibitors targeting these proteins. Galecto's leading product candidate, GB0139, is aimed at treating severe fibrotic lung diseases, notably idiopathic pulmonary fibrosis, while another candidate, GB1211, is a selective oral galectin-3 inhibitor intended for managing fibrosis related to non-alcoholic steatohepatitis. With a robust patent portfolio, Galecto is positioned to address critical unmet medical needs in the treatment of fibrotic and related diseases.
Grandhood is an investment management company based in Copenhagen, Denmark, founded in 2016. It focuses on retirement planning and pension services, aiming to make pension investments more transparent and accessible. The company has developed an online application that enables employers to facilitate retirement planning for their employees. This platform offers various features, including voluntary health insurance and coverage for reduced working capacity, death, and critical illnesses. By providing these services, Grandhood assists small businesses in supporting their employees' retirement readiness.
Private Equity Round in 2018
Blackwood Seven A/S is a Copenhagen-based company that offers an automated media allocation platform designed to enhance the effectiveness of advertising campaigns across various media channels, both online and offline. Founded in 2013, it specializes in video and audio media investments for dynamic businesses. The company employs predictive analytics, utilizing machine learning and artificial intelligence, to optimize media spending and improve return on investment by 15-25%. Its cloud-based platform allows for real-time modeling and comprehensive evaluation of marketing efforts, providing insights into the impact of historical spending and the effectiveness of different media channels. Blackwood Seven has additional locations in Munich, Los Angeles, New York, and Barcelona, serving a diverse clientele looking to maximize their media investments.
Forecast ApS is a software development company based in Copenhagen, Denmark, that specializes in project management solutions. Founded in 2016, Forecast provides a comprehensive platform designed to help professional service organizations streamline their project and resource management. The software integrates various functionalities, including financial management, time tracking, team collaboration, and business intelligence, all powered by artificial intelligence. This intelligent platform enables users to plan, budget, and predict project outcomes effectively. By unifying project-related data, Forecast facilitates better decision-making and enhances operational efficiency, allowing teams to focus on innovation rather than administrative tasks. The company aims to shift the project management paradigm from a project-first approach to a client-first strategy, ultimately delivering improved results for businesses.
Corti is an artificial intelligence platform designed to assist emergency medical dispatchers and healthcare providers in making critical, life-saving decisions. The platform focuses on medical triaging, aiming to reduce errors and enhance the accuracy of human decision-making. By employing advanced speech recognition and natural language processing, Corti analyzes patient interviews and prepares case files prior to consultations. It also suggests relevant questions to ask, enabling healthcare professionals to understand patient situations more effectively. Through these capabilities, Corti aims to improve the speed and accuracy of decision-making in emergency medical contexts, ultimately contributing to better patient outcomes.
Peakon ApS, founded in 2008 and based in Copenhagen, Denmark, specializes in real-time people analytics aimed at enhancing employee engagement and retention. The Peakon platform automatically gathers employee feedback and analyzes it to provide actionable insights for organizations. It supports a diverse range of users by being available in over 50 languages and can accommodate complex organizational structures with tens of thousands of employees. Feedback can be submitted through various channels, including web, mobile browsers, SMS, kiosks, and a native app, enabling organizations to foster an environment where employees can reach their full potential.
Orphazyme A/S is a biopharmaceutical company based in Copenhagen, Denmark, that specializes in developing therapies for neurodegenerative orphan diseases, particularly those linked to protein misfolding such as lysosomal storage diseases. Founded in 2009, the company is focused on its lead candidate, Arimoclomol, which is undergoing clinical trials for multiple orphan diseases, including Niemann-Pick disease type C, Gaucher disease, sporadic inclusion body myositis, and amyotrophic lateral sclerosis. Orphazyme’s research is grounded in academic discoveries from its founders at the Danish Cancer Society, and the company has established collaborations with leading academic institutions in Europe and the United States. In addition, Orphazyme has entered a strategic partnership with CombiGene AB to enhance its research and development efforts in the biopharmaceutical sector.
Natural Cycles is a pioneering company in the field of digital contraception, focusing on female reproductive health through its contraceptive app. The app enables users to track their basal body temperature each morning, which, along with other data such as luteinizing hormone levels, is processed by an algorithm to determine fertility status. By analyzing individual inputs, the app forecasts which days women are fertile, providing a color-coded calendar to indicate when unprotected intercourse may be feasible. Users are required to measure and enter their body temperature daily using a basal thermometer for accurate predictions. This subscription-based service aims to simplify fertility tracking and empower women in managing their reproductive health.
Tink AB, founded in 2012 and headquartered in Stockholm, Sweden, operates as a cloud-based open banking platform that enhances financial services through its infrastructure and data products. The company offers a mobile application that allows users to track personal finances, manage money across various accounts, transfer funds, pay bills, and establish personal budgets. Key features of the application include transaction categorization, spending insights, and daily analyses. Additionally, Tink provides products such as account aggregation, payment initiation, and data enrichment, which can be utilized for standalone services or integrated into existing banking applications. The company's partnerships with major financial institutions, including ABN AMRO, BNP Paribas Fortis, Nordea, Klarna, and SEB, further bolster its position in the financial technology sector.
Fast Travel Games AB is a game development studio based in Stockholm, Sweden, founded in 2016 by veterans from renowned companies such as EA DICE, Rovio, and Avalanche. The studio specializes in creating virtual reality games that emphasize rich narratives and social interaction. Fast Travel Games aims to transform the gaming experience by allowing players to explore immersive environments and engage with each other in innovative ways. The company's focus is on developing games that encourage teamwork and provide deep, engrossing universes for players to enjoy with friends, all supported by VR technology.
RFRSH ApS is an esports marketing and media rights company based in Copenhagen, Denmark, founded in 2016. The company specializes in developing commercial and marketing strategies for esports teams, particularly focusing on the popular game Counter-Strike. RFRSH ApS collaborates with a range of established organizations and emerging player-owned teams to enhance their brand visibility and sports performance. By representing the commercial and media rights of these teams, RFRSH connects them with leading global brands for sponsorship and marketing agreements, thereby facilitating their growth and success in the competitive esports landscape.
Peakon ApS, founded in 2008 and based in Copenhagen, Denmark, specializes in real-time people analytics aimed at enhancing employee engagement and retention. The Peakon platform automatically gathers employee feedback and analyzes it to provide actionable insights for organizations. It supports a diverse range of users by being available in over 50 languages and can accommodate complex organizational structures with tens of thousands of employees. Feedback can be submitted through various channels, including web, mobile browsers, SMS, kiosks, and a native app, enabling organizations to foster an environment where employees can reach their full potential.
Traplight Oy, established in 2010 and located in Tampere, Finland, specializes in developing mobile game communities that emphasize user-generated content. The company focuses on creating free-to-play games that are both accessible and engaging, offering players enjoyable gameplay and a sense of progression. Traplight encourages players to create and share their own games, integrating player-generated levels into the core gaming experience. The company has garnered support from prominent investors and has a team of 28 dedicated professionals working on multiple projects. Their notable title, Big Bang Racing, received recognition as one of the best apps in 2016 on the App Store. Traplight is currently preparing to soft launch its next major game, aiming to provide lasting entertainment that evolves with player preferences.
Orphazyme A/S is a biopharmaceutical company based in Copenhagen, Denmark, that specializes in developing therapies for neurodegenerative orphan diseases, particularly those linked to protein misfolding such as lysosomal storage diseases. Founded in 2009, the company is focused on its lead candidate, Arimoclomol, which is undergoing clinical trials for multiple orphan diseases, including Niemann-Pick disease type C, Gaucher disease, sporadic inclusion body myositis, and amyotrophic lateral sclerosis. Orphazyme’s research is grounded in academic discoveries from its founders at the Danish Cancer Society, and the company has established collaborations with leading academic institutions in Europe and the United States. In addition, Orphazyme has entered a strategic partnership with CombiGene AB to enhance its research and development efforts in the biopharmaceutical sector.
OxThera AB is a biopharmaceutical company based in Stockholm, Sweden, with an additional location in Knoxville, Tennessee. Founded in 2005, it focuses on developing treatments for primary and secondary hyperoxaluria, a condition that can lead to kidney stones and impaired kidney function. The company's leading products include Oxabact, an oral formulation of live bacteria designed to enhance the elimination of oxalate produced in the body, and Oxazyme, a recombinant enzyme aimed at managing dietary oxalate and preventing kidney stone formation. Oxabact has received Orphan Drug designations in both Europe and the United States, underscoring its potential in treating primary hyperoxaluria. OxThera holds global patents for its innovative approaches using bacteria and enzymes to address hyperoxaluria, contributing to advancements in kidney disease management.
Neo4j, Inc. specializes in developing a graph database platform that enables organizations to understand and leverage the relationships within their data. This platform facilitates the connection of various deployments and customer applications, addressing complex data challenges across industries such as financial services, retail, government, and telecommunications. Neo4j's technology supports a range of applications, including artificial intelligence, analytics, fraud detection, identity management, knowledge graphs, and recommendation engines. By adopting a relationships-first approach, the platform helps clients to unlock business value and adapt to changing needs while managing data at scale. Founded in 2007 and headquartered in San Mateo, California, Neo4j also maintains offices in Sweden, the United Kingdom, and France, reinforcing its position as a leader in graph database technology.
Freespee AB is a technology company specializing in call monetization solutions for the performance advertising sector, primarily operating in Europe and North America. Founded in 2008 and headquartered in Uppsala, Sweden, with additional offices in Helsinki, Copenhagen, and Berlin, Freespee provides various products aimed at enhancing communication and marketing efforts. Its offerings include Freespee Performance, which allows publishers and advertising networks to monetize phone calls generated from their media properties, and Freespee Analytics, a comprehensive tool for tracking leads and analyzing call data. Additionally, the Freespee Mobile Tracking SDK assists app developers in understanding consumer engagement through phone calls. By integrating multiple data sources, Freespee aims to facilitate personalized interactions between brands and their customers, thereby improving the overall consumer experience.
Blackwood Seven A/S is a Copenhagen-based company that offers an automated media allocation platform designed to enhance the effectiveness of advertising campaigns across various media channels, both online and offline. Founded in 2013, it specializes in video and audio media investments for dynamic businesses. The company employs predictive analytics, utilizing machine learning and artificial intelligence, to optimize media spending and improve return on investment by 15-25%. Its cloud-based platform allows for real-time modeling and comprehensive evaluation of marketing efforts, providing insights into the impact of historical spending and the effectiveness of different media channels. Blackwood Seven has additional locations in Munich, Los Angeles, New York, and Barcelona, serving a diverse clientele looking to maximize their media investments.
Futureplay Ltd., founded in 2015 and based in Helsinki, Finland, specializes in the development of mobile games for phones and tablets. The company aims to create a new category of "view-to-play" games that provide broadly accessible gameplay while incorporating ad-based monetization. This innovative model allows players to advance in games and earn bonuses by watching short advertisements rather than making micropayments. With a founding team that brings over 60 years of collective experience from renowned gaming companies, Futureplay is committed to producing engaging and delightful gaming experiences. The company focuses on rapid development, aiming to launch multiple games each year, thereby fostering a dynamic approach to mobile gaming that appeals to both new and seasoned players.
Werlabs AB is a medical technology company based in Stockholm, Sweden, founded in 2013 by Will Stoddart and general practitioner Rickard Lagerqvist. The company specializes in direct-to-consumer blood analysis and health checkup services, enabling individuals to monitor and improve their health. Werlabs offers comprehensive health analysis through blood testing, which is reviewed by medical professionals. Customers gain access to a private online journal, providing them with the tools and information necessary to understand their health status and minimize the risk of common diseases. Through its services, Werlabs aims to empower users to take charge of their health.
Fast Travel Games AB is a game development studio based in Stockholm, Sweden, founded in 2016 by veterans from renowned companies such as EA DICE, Rovio, and Avalanche. The studio specializes in creating virtual reality games that emphasize rich narratives and social interaction. Fast Travel Games aims to transform the gaming experience by allowing players to explore immersive environments and engage with each other in innovative ways. The company's focus is on developing games that encourage teamwork and provide deep, engrossing universes for players to enjoy with friends, all supported by VR technology.
Natural Cycles is a pioneering company in the field of digital contraception, focusing on female reproductive health through its contraceptive app. The app enables users to track their basal body temperature each morning, which, along with other data such as luteinizing hormone levels, is processed by an algorithm to determine fertility status. By analyzing individual inputs, the app forecasts which days women are fertile, providing a color-coded calendar to indicate when unprotected intercourse may be feasible. Users are required to measure and enter their body temperature daily using a basal thermometer for accurate predictions. This subscription-based service aims to simplify fertility tracking and empower women in managing their reproductive health.
Tink AB, founded in 2012 and headquartered in Stockholm, Sweden, operates as a cloud-based open banking platform that enhances financial services through its infrastructure and data products. The company offers a mobile application that allows users to track personal finances, manage money across various accounts, transfer funds, pay bills, and establish personal budgets. Key features of the application include transaction categorization, spending insights, and daily analyses. Additionally, Tink provides products such as account aggregation, payment initiation, and data enrichment, which can be utilized for standalone services or integrated into existing banking applications. The company's partnerships with major financial institutions, including ABN AMRO, BNP Paribas Fortis, Nordea, Klarna, and SEB, further bolster its position in the financial technology sector.
Minervax is pursuing the development of a vaccine against Group B streptococcus (GBS) infections by utilizing a particular fusion protein, which has proved to elicit good protective immunity. A vaccine including this fusion protein will likely elicit protective immunity against many clinically relevant GBS strains.
Corti is an artificial intelligence platform designed to assist emergency medical dispatchers and healthcare providers in making critical, life-saving decisions. The platform focuses on medical triaging, aiming to reduce errors and enhance the accuracy of human decision-making. By employing advanced speech recognition and natural language processing, Corti analyzes patient interviews and prepares case files prior to consultations. It also suggests relevant questions to ask, enabling healthcare professionals to understand patient situations more effectively. Through these capabilities, Corti aims to improve the speed and accuracy of decision-making in emergency medical contexts, ultimately contributing to better patient outcomes.
Peakon ApS, founded in 2008 and based in Copenhagen, Denmark, specializes in real-time people analytics aimed at enhancing employee engagement and retention. The Peakon platform automatically gathers employee feedback and analyzes it to provide actionable insights for organizations. It supports a diverse range of users by being available in over 50 languages and can accommodate complex organizational structures with tens of thousands of employees. Feedback can be submitted through various channels, including web, mobile browsers, SMS, kiosks, and a native app, enabling organizations to foster an environment where employees can reach their full potential.
Astralis is a Copenhagen-based professional e-sports organization recognized for its competitive teams, particularly in Counter-Strike, where it ranks among the top teams worldwide. Founded by Frederik Byskov and Jacob Lund Kristensen, along with five prominent players from the Counter-Strike team, Astralis has established itself as a significant player in the global esports industry. The organization not only operates its Counter-Strike team but also manages teams in League of Legends and FIFA, focusing on developing strong sports and entertainment brands. Astralis engages in media partnerships and channels to enhance its brand presence and connect with fans and audiences worldwide.
Traplight Oy, established in 2010 and located in Tampere, Finland, specializes in developing mobile game communities that emphasize user-generated content. The company focuses on creating free-to-play games that are both accessible and engaging, offering players enjoyable gameplay and a sense of progression. Traplight encourages players to create and share their own games, integrating player-generated levels into the core gaming experience. The company has garnered support from prominent investors and has a team of 28 dedicated professionals working on multiple projects. Their notable title, Big Bang Racing, received recognition as one of the best apps in 2016 on the App Store. Traplight is currently preparing to soft launch its next major game, aiming to provide lasting entertainment that evolves with player preferences.
Futureplay Ltd., founded in 2015 and based in Helsinki, Finland, specializes in the development of mobile games for phones and tablets. The company aims to create a new category of "view-to-play" games that provide broadly accessible gameplay while incorporating ad-based monetization. This innovative model allows players to advance in games and earn bonuses by watching short advertisements rather than making micropayments. With a founding team that brings over 60 years of collective experience from renowned gaming companies, Futureplay is committed to producing engaging and delightful gaming experiences. The company focuses on rapid development, aiming to launch multiple games each year, thereby fostering a dynamic approach to mobile gaming that appeals to both new and seasoned players.
Templafy ApS is a B2B Software-as-a-Service company specializing in template and document management solutions. Founded in 2013 and headquartered in Copenhagen, Denmark, Templafy offers a comprehensive platform that enhances productivity, branding, and compliance across various business documents, presentations, and emails. Its services include template and content accessibility, dynamic personalization, document automation, and brand validation, catering primarily to sectors such as banking, finance, consulting, education, insurance, consumer goods, and legal services. With a user base exceeding 1.5 million, Templafy streamlines the document creation workflow, allowing communication and compliance teams to maintain control while ensuring an enjoyable user experience for employees. The company has expanded its presence internationally, with offices in the United States, Germany, the Netherlands, the United Kingdom, Singapore, Hong Kong, Australia, New Zealand, and Spain, serving a diverse range of enterprise customers globally.
Metacore Games Oy is a gaming company based in Helsinki, Finland, with a focus on developing engaging mobile games. Founded in 2014, the company gained significant recognition with the launch of its first global hit, Merge Mansion, in 2020, which has attracted over 50 million players. Metacore has quickly established itself as one of the fastest-growing game companies in Europe, reporting EUR 129 million in revenue in 2022. The company employs a team of over 170 professionals and has evolved from its earlier focus on creating award-winning smartwatch games under the name Everywear Games to concentrate on mobile gaming.
Boozt Fashion AB is an e-commerce company based in Malmö, Sweden, founded in 2007. It specializes in selling a wide range of clothing, shoes, and accessories for women, men, and children. The company's product offerings include apparel, sportswear, bags, innerwear, and various accessories. Boozt operates webshops for multiple prominent Nordic fashion brands, covering the Northern European market. In addition to its own platform, it provides e-commerce solutions that integrate online and offline channels for Scandinavian apparel companies. With a workforce of approximately 45 employees in Sweden and an offshore team in Vietnam and India, Boozt continues to expand its brand partnerships and enhance its online retail capabilities.
Natural Cycles is a pioneering company in the field of digital contraception, focusing on female reproductive health through its contraceptive app. The app enables users to track their basal body temperature each morning, which, along with other data such as luteinizing hormone levels, is processed by an algorithm to determine fertility status. By analyzing individual inputs, the app forecasts which days women are fertile, providing a color-coded calendar to indicate when unprotected intercourse may be feasible. Users are required to measure and enter their body temperature daily using a basal thermometer for accurate predictions. This subscription-based service aims to simplify fertility tracking and empower women in managing their reproductive health.
Ministry of Games is a mobile game development studio that designs and develops games focused on experience. It aims to bring RPGs to mobile platforms. The company is backed by Initial Capital, Index Ventures, Sunstone Capital, Proxy Ventures, Henric Suuronen, Markus Pasula, and Tekes. Ministry of Games was founded in 2014 and is based in Helsinki, Finland.
Blackwood Seven A/S is a Copenhagen-based company that offers an automated media allocation platform designed to enhance the effectiveness of advertising campaigns across various media channels, both online and offline. Founded in 2013, it specializes in video and audio media investments for dynamic businesses. The company employs predictive analytics, utilizing machine learning and artificial intelligence, to optimize media spending and improve return on investment by 15-25%. Its cloud-based platform allows for real-time modeling and comprehensive evaluation of marketing efforts, providing insights into the impact of historical spending and the effectiveness of different media channels. Blackwood Seven has additional locations in Munich, Los Angeles, New York, and Barcelona, serving a diverse clientele looking to maximize their media investments.
Neo4j, Inc. specializes in developing a graph database platform that enables organizations to understand and leverage the relationships within their data. This platform facilitates the connection of various deployments and customer applications, addressing complex data challenges across industries such as financial services, retail, government, and telecommunications. Neo4j's technology supports a range of applications, including artificial intelligence, analytics, fraud detection, identity management, knowledge graphs, and recommendation engines. By adopting a relationships-first approach, the platform helps clients to unlock business value and adapt to changing needs while managing data at scale. Founded in 2007 and headquartered in San Mateo, California, Neo4j also maintains offices in Sweden, the United Kingdom, and France, reinforcing its position as a leader in graph database technology.
Orphazyme A/S is a biopharmaceutical company based in Copenhagen, Denmark, that specializes in developing therapies for neurodegenerative orphan diseases, particularly those linked to protein misfolding such as lysosomal storage diseases. Founded in 2009, the company is focused on its lead candidate, Arimoclomol, which is undergoing clinical trials for multiple orphan diseases, including Niemann-Pick disease type C, Gaucher disease, sporadic inclusion body myositis, and amyotrophic lateral sclerosis. Orphazyme’s research is grounded in academic discoveries from its founders at the Danish Cancer Society, and the company has established collaborations with leading academic institutions in Europe and the United States. In addition, Orphazyme has entered a strategic partnership with CombiGene AB to enhance its research and development efforts in the biopharmaceutical sector.
Traplight Oy, established in 2010 and located in Tampere, Finland, specializes in developing mobile game communities that emphasize user-generated content. The company focuses on creating free-to-play games that are both accessible and engaging, offering players enjoyable gameplay and a sense of progression. Traplight encourages players to create and share their own games, integrating player-generated levels into the core gaming experience. The company has garnered support from prominent investors and has a team of 28 dedicated professionals working on multiple projects. Their notable title, Big Bang Racing, received recognition as one of the best apps in 2016 on the App Store. Traplight is currently preparing to soft launch its next major game, aiming to provide lasting entertainment that evolves with player preferences.
Pulmologix AB is a Swedish private clinical stage company focused on developing, manufacturing, and selling an oral non-steroidal anti-asthmatic drug designed for the treatment of early onset allergic asthma. Established in 2006 and headquartered in Stockholm, the company aims to address unmet medical needs in asthma management through its innovative therapeutic approach.
Tink AB, founded in 2012 and headquartered in Stockholm, Sweden, operates as a cloud-based open banking platform that enhances financial services through its infrastructure and data products. The company offers a mobile application that allows users to track personal finances, manage money across various accounts, transfer funds, pay bills, and establish personal budgets. Key features of the application include transaction categorization, spending insights, and daily analyses. Additionally, Tink provides products such as account aggregation, payment initiation, and data enrichment, which can be utilized for standalone services or integrated into existing banking applications. The company's partnerships with major financial institutions, including ABN AMRO, BNP Paribas Fortis, Nordea, Klarna, and SEB, further bolster its position in the financial technology sector.
Issuu, Inc. is a digital publishing and discovery platform founded in 2006 in Copenhagen, Denmark. It provides a range of solutions that allow users to create, publish, and share digital publications such as magazines, catalogs, and corporate literature. The platform hosts over 17 million publications and attracts more than 80 million active readers monthly, delivering approximately 5.5 billion page views. Issuu's offerings include tools for custom viewer themes, API integrations for managing content, and monetization solutions through Issuu Story Cloud. The platform is designed to enhance the reading experience by transforming PDFs and images into visually appealing formats accessible across various devices and social media. With additional offices in Palo Alto, California, and Berlin, Germany, Issuu serves a diverse audience, including designers, developers, publishers, and advertisers, ultimately aiming to democratize the publishing experience while preserving the essence of print media.
Templafy ApS is a B2B Software-as-a-Service company specializing in template and document management solutions. Founded in 2013 and headquartered in Copenhagen, Denmark, Templafy offers a comprehensive platform that enhances productivity, branding, and compliance across various business documents, presentations, and emails. Its services include template and content accessibility, dynamic personalization, document automation, and brand validation, catering primarily to sectors such as banking, finance, consulting, education, insurance, consumer goods, and legal services. With a user base exceeding 1.5 million, Templafy streamlines the document creation workflow, allowing communication and compliance teams to maintain control while ensuring an enjoyable user experience for employees. The company has expanded its presence internationally, with offices in the United States, Germany, the Netherlands, the United Kingdom, Singapore, Hong Kong, Australia, New Zealand, and Spain, serving a diverse range of enterprise customers globally.
In 2013, the company's first spinal fusion implant in the Statur product line received CE mark. At the same time, the company was ISO 13485 certified demonstrating its adherence to the highest quality standards. With these accomplishments, the company is now ready to be introduced on the European and Canadian markets.
In early 2005, FBC Device was founded. With initial financial support in place, FBC Device was established and initial patents filed in late 2005. In December 2010, the European patent was granted and further funding raised, and in 2011 the US patent was granted.
Minervax is pursuing the development of a vaccine against Group B streptococcus (GBS) infections by utilizing a particular fusion protein, which has proved to elicit good protective immunity. A vaccine including this fusion protein will likely elicit protective immunity against many clinically relevant GBS strains.
addwish is a provider of wish list services for both consumers and online shops. Consumers can easily create wishlists to share with their family and friends. The highly intuitive interface on both addwish.com and on its iOS and Android mobile apps makes gift giving easier than ever before. For online retailers, addwish supplies a webshop plugin that enables the addwish functionality directly on their websites. As added benefit for the merchants, addwish promotes and suggests the products from their webshops to its users, resulting in traffic and lead generation.
Galecto, Inc. is a clinical-stage biotechnology company founded in 2011, focused on developing small molecules to treat severe diseases, particularly fibrosis and cancer. The company leverages over a decade of research on the roles of galectin-3 and lysyl oxidase-like 2 (LOXL2) in fibrotic processes. Its therapeutic approach includes small-molecule inhibitors targeting these proteins. Galecto's leading product candidate, GB0139, is aimed at treating severe fibrotic lung diseases, notably idiopathic pulmonary fibrosis, while another candidate, GB1211, is a selective oral galectin-3 inhibitor intended for managing fibrosis related to non-alcoholic steatohepatitis. With a robust patent portfolio, Galecto is positioned to address critical unmet medical needs in the treatment of fibrotic and related diseases.
Blackwood Seven A/S is a Copenhagen-based company that offers an automated media allocation platform designed to enhance the effectiveness of advertising campaigns across various media channels, both online and offline. Founded in 2013, it specializes in video and audio media investments for dynamic businesses. The company employs predictive analytics, utilizing machine learning and artificial intelligence, to optimize media spending and improve return on investment by 15-25%. Its cloud-based platform allows for real-time modeling and comprehensive evaluation of marketing efforts, providing insights into the impact of historical spending and the effectiveness of different media channels. Blackwood Seven has additional locations in Munich, Los Angeles, New York, and Barcelona, serving a diverse clientele looking to maximize their media investments.
Cantargia AB is a biotechnology company based in Lund, Sweden, focused on developing antibody-based therapies for serious diseases, particularly cancer and autoimmune conditions. The company specializes in targeting the Interleukin-1 Receptor Accessory Protein (IL1RAP), which is expressed in certain leukemic stem cells and various cancers. Its lead product candidate, CAN04, is designed to recognize and bind to cancer cells, enhancing the immune system's ability to eliminate these cells while also reducing tumor-related inflammation. Cantargia is also working on additional antibody candidates, including CAN10, to address a broader range of diseases. Founded in 2010, the company has established collaborations to further its research and development efforts.
Mofibo, founded in Copenhagen in 2013, operates as one of the pioneering book subscription services globally. The company provides access to e-books through a proprietary platform, allowing consumers to enjoy a wide selection of titles for a monthly subscription fee. Currently available in three countries, Mofibo aims to expand its reach into additional markets within the next year. The company focuses on transforming the reading experience by employing a data-driven and customer-centric approach, seeking to enhance how millions of people engage with books.
Neo4j, Inc. specializes in developing a graph database platform that enables organizations to understand and leverage the relationships within their data. This platform facilitates the connection of various deployments and customer applications, addressing complex data challenges across industries such as financial services, retail, government, and telecommunications. Neo4j's technology supports a range of applications, including artificial intelligence, analytics, fraud detection, identity management, knowledge graphs, and recommendation engines. By adopting a relationships-first approach, the platform helps clients to unlock business value and adapt to changing needs while managing data at scale. Founded in 2007 and headquartered in San Mateo, California, Neo4j also maintains offices in Sweden, the United Kingdom, and France, reinforcing its position as a leader in graph database technology.
Freespee AB is a technology company specializing in call monetization solutions for the performance advertising sector, primarily operating in Europe and North America. Founded in 2008 and headquartered in Uppsala, Sweden, with additional offices in Helsinki, Copenhagen, and Berlin, Freespee provides various products aimed at enhancing communication and marketing efforts. Its offerings include Freespee Performance, which allows publishers and advertising networks to monetize phone calls generated from their media properties, and Freespee Analytics, a comprehensive tool for tracking leads and analyzing call data. Additionally, the Freespee Mobile Tracking SDK assists app developers in understanding consumer engagement through phone calls. By integrating multiple data sources, Freespee aims to facilitate personalized interactions between brands and their customers, thereby improving the overall consumer experience.
Santaris Pharma A/S is a clinical-stage biopharmaceutical company specializing in RNA-targeted therapies. Founded in 2003 and headquartered in Denmark, the company utilizes its proprietary Locked Nucleic Acid (LNA) Drug Platform and Drug Discovery Engine to develop single-stranded LNA-based drug candidates for various diseases. Its research focuses on infectious diseases and cardiometabolic disorders, while also addressing cancer, cardiovascular diseases, inflammatory diseases, and rare genetic disorders through collaborations with major pharmaceutical firms. Santaris Pharma has established partnerships with organizations such as miRagen Therapeutics, Shire, Pfizer, GlaxoSmithKline, and Enzon Pharmaceuticals. The company holds exclusive worldwide rights to manufacture and sell products containing LNA as an active ingredient, which supports its goal of obtaining marketing approval for its innovative therapies.
Nuevolution A/S is a biopharmaceutical company based in Copenhagen, Denmark, founded in 2001. The company specializes in developing drug treatments for oncology and chronic inflammatory diseases. Nuevolution has created Chemetics®, an innovative drug discovery platform that combines wet chemistry and molecular biology to facilitate the rapid synthesis and screening of over one billion small molecule compounds. This technology allows for the efficient identification of potent drug candidates. The company's pipeline includes several programs such as ROR?t inhibitors and IL-17A inhibitors aimed at treating various diseases. Nuevolution collaborates with major pharmaceutical and biotechnology companies, entering into agreements with firms like Amgen and GlaxoSmithKline. Additionally, the company engages in contract research services, contributing to its revenue generation across multiple markets including Denmark, Sweden, and the USA. As a privately owned entity, Nuevolution is supported by key Scandinavian investors.
Adenium Biotech ApS is a Danish biopharmaceutical company founded in 2011, focused on developing and commercializing innovative antibiotics to address multi-drug resistant bacterial infections. The company specializes in solutions for hospital-acquired infections, particularly complicated urinary tract infections and pneumonia caused by resistant gram-negative bacteria such as Escherichia coli, Pseudomonas aeruginosa, and Klebsiella pneumoniae. Its lead product, Arenicin, is a non-toxic antimicrobial peptide derived from lugworms, demonstrating strong efficacy against gram-negative pathogens. Adenium Biotech employs a semi-virtual model, leveraging a small team of experts and an international scientific advisory board to advance the Arenicin program through clinical development towards regulatory approval. The company's goal is to provide effective treatments for infections that are increasingly difficult to manage due to antibiotic resistance.
Neo4j, Inc. specializes in developing a graph database platform that enables organizations to understand and leverage the relationships within their data. This platform facilitates the connection of various deployments and customer applications, addressing complex data challenges across industries such as financial services, retail, government, and telecommunications. Neo4j's technology supports a range of applications, including artificial intelligence, analytics, fraud detection, identity management, knowledge graphs, and recommendation engines. By adopting a relationships-first approach, the platform helps clients to unlock business value and adapt to changing needs while managing data at scale. Founded in 2007 and headquartered in San Mateo, California, Neo4j also maintains offices in Sweden, the United Kingdom, and France, reinforcing its position as a leader in graph database technology.
Orphazyme A/S is a biopharmaceutical company based in Copenhagen, Denmark, that specializes in developing therapies for neurodegenerative orphan diseases, particularly those linked to protein misfolding such as lysosomal storage diseases. Founded in 2009, the company is focused on its lead candidate, Arimoclomol, which is undergoing clinical trials for multiple orphan diseases, including Niemann-Pick disease type C, Gaucher disease, sporadic inclusion body myositis, and amyotrophic lateral sclerosis. Orphazyme’s research is grounded in academic discoveries from its founders at the Danish Cancer Society, and the company has established collaborations with leading academic institutions in Europe and the United States. In addition, Orphazyme has entered a strategic partnership with CombiGene AB to enhance its research and development efforts in the biopharmaceutical sector.
Orphazyme A/S is a biopharmaceutical company based in Copenhagen, Denmark, that specializes in developing therapies for neurodegenerative orphan diseases, particularly those linked to protein misfolding such as lysosomal storage diseases. Founded in 2009, the company is focused on its lead candidate, Arimoclomol, which is undergoing clinical trials for multiple orphan diseases, including Niemann-Pick disease type C, Gaucher disease, sporadic inclusion body myositis, and amyotrophic lateral sclerosis. Orphazyme’s research is grounded in academic discoveries from its founders at the Danish Cancer Society, and the company has established collaborations with leading academic institutions in Europe and the United States. In addition, Orphazyme has entered a strategic partnership with CombiGene AB to enhance its research and development efforts in the biopharmaceutical sector.
Podio ApS is a collaborative work platform based in Copenhagen, Denmark, that allows organizations to manage their workflows more effectively. Founded in 2007, Podio provides users with tools to share files, manage tasks, and create custom applications, enabling a tailored work environment. The platform integrates various functionalities, including messaging, reporting, and workflow management, to streamline work processes and reduce reliance on multiple disparate tools. Accessible via desktop and mobile applications, Podio enables real-time collaboration among team members. Since becoming a subsidiary of Citrix Systems, Podio has garnered a global user base, supporting diverse teams and organizations in optimizing their work activities.
Acarix A/S is a medical device company based in Kongens Lyngby, Denmark, specializing in the non-invasive detection of coronary artery disease (CAD). Founded in 2009, Acarix developed the CADScor System, which utilizes advanced acoustics and artificial intelligence to provide a rapid diagnosis for patients experiencing chest pain. The system is designed to accurately rule out CAD in under ten minutes, significantly reducing the need for unnecessary invasive procedures and associated costs. Acarix operates in several markets, including Germany, Sweden, and Denmark, and has received both CE marking and DeNovo approval from the FDA for its CADScor System. The company's foundation is rooted in research from Aalborg University, and it has garnered support from various investors and public funding initiatives to advance its innovative solutions in the field of cardiovascular diagnostics.
Microtask Oy is a company that specializes in human-powered document processing and data entry services, utilizing a proprietary software platform to enhance efficiency. Founded in 2009 and headquartered in Tampere, Finland, with additional offices in Helsinki, Atlanta, and San Francisco, Microtask's platform breaks down repetitive tasks into small, manageable units. These tasks can be completed quickly by digital workers around the globe, allowing for streamlined operations. The company operates on a pay-as-you-go pricing model, treating the results of labor as a commodity. This innovative approach optimizes quality, speed, and processing costs, making it easier for clients to handle large volumes of work efficiently.
Action Pharma A/S develops novel drugs for cardio vascular treatment. The company also conducts pre-clinical and early clinical trials of new pharmaceutical products and treatment concepts for cardiovascular, inflammatory, and acquired metabolic diseases. Its products include COMPOUND AP1189, an oral anti-inflammatory compound under development for the treatment of inflammatory diseases, such as inflammatory bowel disease and rheumatoid arthritis; and COMPOUND AP405, a modified MSH peptide analogue under development for the treatment of inflammatory skin diseases, such as atopic dermatitis. Action Pharma A/S was founded in 2000 and is based in Aarhus, Denmark.
Neo4j, Inc. specializes in developing a graph database platform that enables organizations to understand and leverage the relationships within their data. This platform facilitates the connection of various deployments and customer applications, addressing complex data challenges across industries such as financial services, retail, government, and telecommunications. Neo4j's technology supports a range of applications, including artificial intelligence, analytics, fraud detection, identity management, knowledge graphs, and recommendation engines. By adopting a relationships-first approach, the platform helps clients to unlock business value and adapt to changing needs while managing data at scale. Founded in 2007 and headquartered in San Mateo, California, Neo4j also maintains offices in Sweden, the United Kingdom, and France, reinforcing its position as a leader in graph database technology.
Biomonitor, founded in 2003 by Professor Klaus Bendtzen and Arsalan Kharazmi as a spinout from the University of Copenhagen, specializes in pharmaceutical development services. The company leverages Professor Bendtzen's extensive research experience in inflammation and immunology, particularly his discoveries related to patient responses to biopharmaceuticals. It has been established that some patients develop antibodies against the proteins and peptides used in these treatments, which can hinder their efficacy. Consequently, Biomonitor focuses on creating methods to monitor these biopharmaceuticals, ensuring that patients receive optimal therapeutic benefits. Since its inception, the company has experienced significant growth, reflecting its commitment to improving patient care in chronic disease management.
Action Pharma A/S develops novel drugs for cardio vascular treatment. The company also conducts pre-clinical and early clinical trials of new pharmaceutical products and treatment concepts for cardiovascular, inflammatory, and acquired metabolic diseases. Its products include COMPOUND AP1189, an oral anti-inflammatory compound under development for the treatment of inflammatory diseases, such as inflammatory bowel disease and rheumatoid arthritis; and COMPOUND AP405, a modified MSH peptide analogue under development for the treatment of inflammatory skin diseases, such as atopic dermatitis. Action Pharma A/S was founded in 2000 and is based in Aarhus, Denmark.
**World's largest library of user generated, shareable analytics apps** youcalc let's business people create and share custom reports and analytics on data from SaaS systems — zero coding required! A user driven library of now more than 130 analytics apps for CRM, sales, marketing, service/support and project management, and live data connection to a growing number of SaaS systems (Salesforce.com, Basecamp, AdWords, Google Analytics, Highrise CRM, MailChimp, etc.) **User driven innovation and collaboration** The reporting needs of e.g. sales people are different, but a sales guy in New York may share "custom needs" with a sales guy in another company in Rome. youcalc's mission is to create the world's largest library of analytics apps by allowing business users to create and share analytics apps. All apps built on youcalc become public from the app library, for anyone to use as is or customize to individual needs. All customized apps go back into the app library for the benefit of other users. youcalc let's business users across the world search and use a vast library of analytics apps built by other users with similar needs. **Run anywhere - in iGoogle, inside e.g. Salesforce.com, on intranets, on iPhones, etc.** youcalc apps are easy-to-use, interactive, Flash charts that run anywhere - built for business users, not for expert analysts! Stop spending hours clicking through expert analytics interfaces. Business users get the exact analysis they need, with one click, anywhere they want. Add several apps to iGoogle and you have a personal portal for reporting across all your SaaS systems.
Santaris Pharma A/S is a clinical-stage biopharmaceutical company specializing in RNA-targeted therapies. Founded in 2003 and headquartered in Denmark, the company utilizes its proprietary Locked Nucleic Acid (LNA) Drug Platform and Drug Discovery Engine to develop single-stranded LNA-based drug candidates for various diseases. Its research focuses on infectious diseases and cardiometabolic disorders, while also addressing cancer, cardiovascular diseases, inflammatory diseases, and rare genetic disorders through collaborations with major pharmaceutical firms. Santaris Pharma has established partnerships with organizations such as miRagen Therapeutics, Shire, Pfizer, GlaxoSmithKline, and Enzon Pharmaceuticals. The company holds exclusive worldwide rights to manufacture and sell products containing LNA as an active ingredient, which supports its goal of obtaining marketing approval for its innovative therapies.
**World's largest library of user generated, shareable analytics apps** youcalc let's business people create and share custom reports and analytics on data from SaaS systems — zero coding required! A user driven library of now more than 130 analytics apps for CRM, sales, marketing, service/support and project management, and live data connection to a growing number of SaaS systems (Salesforce.com, Basecamp, AdWords, Google Analytics, Highrise CRM, MailChimp, etc.) **User driven innovation and collaboration** The reporting needs of e.g. sales people are different, but a sales guy in New York may share "custom needs" with a sales guy in another company in Rome. youcalc's mission is to create the world's largest library of analytics apps by allowing business users to create and share analytics apps. All apps built on youcalc become public from the app library, for anyone to use as is or customize to individual needs. All customized apps go back into the app library for the benefit of other users. youcalc let's business users across the world search and use a vast library of analytics apps built by other users with similar needs. **Run anywhere - in iGoogle, inside e.g. Salesforce.com, on intranets, on iPhones, etc.** youcalc apps are easy-to-use, interactive, Flash charts that run anywhere - built for business users, not for expert analysts! Stop spending hours clicking through expert analytics interfaces. Business users get the exact analysis they need, with one click, anywhere they want. Add several apps to iGoogle and you have a personal portal for reporting across all your SaaS systems.
Issuu, Inc. is a digital publishing and discovery platform founded in 2006 in Copenhagen, Denmark. It provides a range of solutions that allow users to create, publish, and share digital publications such as magazines, catalogs, and corporate literature. The platform hosts over 17 million publications and attracts more than 80 million active readers monthly, delivering approximately 5.5 billion page views. Issuu's offerings include tools for custom viewer themes, API integrations for managing content, and monetization solutions through Issuu Story Cloud. The platform is designed to enhance the reading experience by transforming PDFs and images into visually appealing formats accessible across various devices and social media. With additional offices in Palo Alto, California, and Berlin, Germany, Issuu serves a diverse audience, including designers, developers, publishers, and advertisers, ultimately aiming to democratize the publishing experience while preserving the essence of print media.